Authors:
ANDREASSEN OA
MACEWAN T
GULBRANDSEN AK
MCCREADIE RG
STEEN VM
Citation: Oa. Andreassen et al., NONFUNCTIONAL CYP2D6 ALLELES AND RISK FOR NEUROLEPTICS-INDUCED MOVEMENT-DISORDERS IN SCHIZOPHRENIC-PATIENTS, Psychopharmacology, 131(2), 1997, pp. 174-179
Citation: Vm. Steen et al., DOPAMINE D3-RECEPTOR GENE VARIANT AND SUSCEPTIBILITY TO TARDIVE-DYSKINESIA IN SCHIZOPHRENIC-PATIENTS, Molecular psychiatry, 2(2), 1997, pp. 139-145
Authors:
LOVLIE R
GULBRANDSEN AK
SJOHOLT G
MACEWAN T
MCCREADIE RG
BERLE J
STEEN VM
Citation: R. Lovlie et al., PHARMACOGENETIC PREDICTION OF THE THERAPEUTIC EFFICACY AND RISK OF SIDE-EFFECTS DURING PSYCHOPHARMACOLOGICAL TREATMENT, Nordic journal of psychiatry, 51(2), 1997, pp. 87-87
Authors:
STEEN VM
LOVLIE R
ANDREASSEN OA
DANIELSEN E
MACEWAN T
GULBRANDSEN AK
MCCREADIE RG
Citation: Vm. Steen et al., IDENTIFICATION OF GENETIC SUSCEPTIBILITY FACTORS FOR THE DEVELOPMENT OF TARDIVE-DYSKINESIA IN SCHIZOPHRENIC-PATIENTS RECEIVING ANTIPSYCHOTIC DRUG-THERAPY, Nordic journal of psychiatry, 51(2), 1997, pp. 105-105
Authors:
MCCREADIE RG
LEESE M
TILAKSINGH D
LOFTUS L
MACEWAN T
THORNICROFT G
Citation: Rg. Mccreadie et al., NITHSDALE, NUNHEAD AND NORWOOD - SIMILARITIES AND DIFFERENCES IN PREVALENCE OF SCHIZOPHRENIA AND UTILIZATION OF SERVICES IN RURAL AND URBANAREAS, British Journal of Psychiatry, 170, 1997, pp. 31-36